David W. Litchfield

London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Platelet Casein Kinase 2α is a pivotal player in arterial thrombotic occlusion and post-ischemic myocardial remodeling.

Platelet Casein Kinase 2α is a pivotal player in arterial thrombotic occlusion and post-ischemic myocardial remodeling.

Journal: Cardiovascular research

Published: February 10, 2025

Novel Pannexin 1 isoform is increased in cancer.

Novel Pannexin 1 isoform is increased in cancer.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Body weight control via protein kinase CK2: diet-induced obesity counteracted by pharmacological targeting.

Body weight control via protein kinase CK2: diet-induced obesity counteracted by pharmacological targeting.

Journal: Metabolism: clinical and experimental

Published: September 02, 2024

Covalent Inhibition of the Peptidyl-Prolyl Isomerase Pin1 by Sulfopin Results in a Broad Impact on the Phosphoproteome of Human Osteosarcoma U2-OS Cells.

Covalent Inhibition of the Peptidyl-Prolyl Isomerase Pin1 by Sulfopin Results in a Broad Impact on the Phosphoproteome of Human Osteosarcoma U2-OS Cells.

Journal: Proteomics

Published: July 30, 2024

Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells.

Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells.

Journal: Cancer cell international

Published: June 24, 2024

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines.

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines.

Journal: Biomedicines

Published: June 29, 2023

Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.

Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.

Journal: Cell death & disease

Published: May 04, 2023

Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target.

Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target.

Journal: Biochimica et biophysica acta. General subjects

Published: April 04, 2023

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2.

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2.

Journal: Current research in chemical biology

Published: January 01, 2023

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.

Journal: Nature chemical biology

Published: June 16, 2022

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.

Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics.

Journal: Frontiers in molecular biosciences

Published: March 31, 2022

Pannexin 2 is expressed in murine skin and promotes UVB-induced apoptosis of keratinocytes.

Pannexin 2 is expressed in murine skin and promotes UVB-induced apoptosis of keratinocytes.

Journal: Molecular biology of the cell

Published: January 05, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026